Table 2.
Measure and Outcome | Quartile I | Quartile 2 | Quartile 3 | Quartile 4 |
---|---|---|---|---|
Cystatin C and Prevalent AF |
||||
Range of Values — mg/liter |
≤0.92 | 0.93-1.05 | 1.06-1.22 | ≥1.23 |
No. | 1172 | 1227 | 1108 | 1156 |
No. with prevalent atrial fibrillation |
48 | 66 | 97 | 131 |
Odds Ratio (95% CI) | ||||
Unadjusted | 1.00 | 1.19 (0.80-1.76) | 2.00 (1.38-2.88) | 2.87 (2.03-4.07) |
Adjusted* | 1.00 | 1.05 (0.71-1.57) | 1.52 (1.03-2.23) | 1.53 (1.03-2.28) |
Cystatin C and Incident AF |
||||
Range of Values — mg/liter |
≤0.92 | 0.93-1.05 | 1.06-1.22 | ≥1.23 |
No. at risk | 1124 | 1161 | 1011 | 1025 |
No. with incident atrial Fibrillation |
111 | 162 | 141 | 165 |
Hazard Ratio (95% CI) | ||||
Unadjusted | 1.00 | 1.37 (1.07-1.75) | 1.43 (1.11-1.84) | 1.88 (1.47-2.41) |
Adjusted* | 1.00 | 1.21 (0.95-1.55) | 1.11 (0.85-1.44) | 1.14 (0.87-1.50) |
Adjusted for age, gender, race, diabetes , CRP, LDL, HDL, prevalent CHD, prevalent CHF, left ventricular hypertrophy, SBP, DBP, use of angiotensin converting enzyme inhibitor, beta blocker, calcium channel blocker and diuretic.